BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16172484)

  • 1. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals.
    Tobón AM; Agudelo CA; Rosero DS; Ochoa JE; De Bedout C; Zuluaga A; Arango M; Cano LE; Sampedro J; Restrepo A
    Am J Trop Med Hyg; 2005 Sep; 73(3):576-82. PubMed ID: 16172484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.
    Goldman M; Zackin R; Fichtenbaum CJ; Skiest DJ; Koletar SL; Hafner R; Wheat LJ; Nyangweso PM; Yiannoutsos CT; Schnizlein-Bick CT; Owens S; Aberg JA;
    Clin Infect Dis; 2004 May; 38(10):1485-9. PubMed ID: 15156489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated histoplasmosis in acquired immunodeficiency syndrome patients in Uberaba, MG, Brazil.
    Mora DJ; dos Santos CT; Silva-Vergara ML
    Mycoses; 2008 Mar; 51(2):136-40. PubMed ID: 18254750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in leptin serum levels in HIV-infected children receiving highly active antiretroviral therapy.
    Papaevangelou V; Papassotiriou I; Vounatsou M; Chrousos G; Theodoridou M
    Scand J Clin Lab Invest; 2007; 67(3):291-6. PubMed ID: 17454843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evidence of interaction between itraconazole and nonnucleoside reverse transcriptase inhibitors in HIV-infected patients with disseminated histoplasmosis.
    Andrade RA; Evans RT; Hamill RJ; Zerai T; Giordano TP
    Ann Pharmacother; 2009 May; 43(5):908-13. PubMed ID: 19401476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histoplasmosis and penicilliosis: comparison of clinical features, laboratory findings and outcome.
    Mootsikapun P; Srikulbutr S
    Int J Infect Dis; 2006 Jan; 10(1):66-71. PubMed ID: 16242368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy.
    Gervasoni C; Ridolfo AL; Vaccarezza M; Parravicini C; Vago L; Adorni F; Cappelletti A; d'Arminio Monforte A; Galli M
    Clin Infect Dis; 2002 Dec; 35(12):1534-40. PubMed ID: 12471574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome.
    Wheat LJ; Connolly P; Smedema M; Brizendine E; Hafner R;
    Clin Infect Dis; 2001 Dec; 33(11):1910-3. PubMed ID: 11692303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
    Gandhi T; Wei W; Amin K; Kazanjian P
    Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated histoplasmosis in patients with AIDS in Panama: a review of 104 cases.
    Gutierrez ME; Canton A; Sosa N; Puga E; Talavera L
    Clin Infect Dis; 2005 Apr; 40(8):1199-202. PubMed ID: 15791523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of the treatment and secondary antifungal prophylaxis in AIDS-related histoplasmosis. Experience at the Francisco J. Muñiz Infectious Diseases Hospital in Buenos Aires].
    Negroni R; Messina F; Arechavala A; Santiso G; Bianchi M
    Rev Iberoam Micol; 2017; 34(2):94-98. PubMed ID: 28391953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
    Akerele T; Galatowicz G; Bunce C; Calder V; Lynn WA; Lightman S
    Clin Immunol; 2006 Nov; 121(2):191-7. PubMed ID: 16987710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras.
    Peigne V; Dromer F; Elie C; Lidove O; Lortholary O;
    Am J Trop Med Hyg; 2011 Nov; 85(5):934-41. PubMed ID: 22049053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interruption of antifungal secondary prophylaxis in AIDS-related histoplasmosis].
    Negroni R; Helou SH; López-Daneri G; Robles AM; Arechavala AI; Bianchi MH
    Rev Iberoam Micol; 2004 Jun; 21(2):75-8. PubMed ID: 15538831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin.
    Olawumi HO; Olatunji PO; Salami AK; Odeigah L; Iseniyi JO
    Niger J Clin Pract; 2008 Dec; 11(4):312-5. PubMed ID: 19320401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful discontinuation of high-dose fluconazole for Histoplasma capsulatum meningitis in an AIDS patient after sustained immune reconstitution.
    Jenny-Avital E
    Clin Infect Dis; 2004 Oct; 39(8):1261-2. PubMed ID: 15486865
    [No Abstract]   [Full Text] [Related]  

  • 19. Paracoccidioidomycosis in patients infected with and not infected with human immunodeficiency virus: a case-control study.
    Morejón KM; Machado AA; Martinez R
    Am J Trop Med Hyg; 2009 Mar; 80(3):359-66. PubMed ID: 19270282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
    Mitsuyasu R; Gelman R; Cherng DW; Landay A; Fahey J; Reichman R; Erice A; Bucy RP; Kilby JM; Lederman MM; Hamilton CD; Lertora J; White BL; Tebas P; Duliege AM; Pollard RB;
    Arch Intern Med; 2007 Mar; 167(6):597-605. PubMed ID: 17389292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.